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Abstract 
We investigate the impact of dipper status on cardiac structure with cardiovascular 
magnetic resonance (CMR). Ambulatory blood pressure monitoring and 1.5T CMR 
were performed in 99 tertiary hypertension clinic patients. Subgroup analysis by 
extreme dipper (n=9), dipper (n=39), non-dipper (n=35) and reverse dipper (n=16) 
status was performed, matched in age, gender and BMI. Left ventricular (LV) mass 
was significantly higher for extreme dippers than dippers after correction for 
covariates (100±6g/m2 vs 79±3g/m2, P=0.004). Amongst extreme dipper and dippers 
(n=48), indexed LV mass correlated positively with the extent of nocturnal blood 
pressure dipping (R=0.403, P=0.005). On post-hoc ANCOVA, the percentage of 
nocturnal dip had significant effect on indexed LV mass (P=0.008), but overall SBP 
did not (P=0.348). In the tertiary setting, we found a larger nocturnal BP drop was 
associated with more LV hypertrophy. If confirmed in larger studies, this may have 
implications on nocturnal dosing of anti-hypertensive medications. 
 
 
 
 
 
 
 
 
 
  
 
Text 
Introduction 
The global burden of systemic hypertension is immense, affecting an estimated 25% 
of the Worldwide adult population and the prevalence of the disease is estimated to 
reach 1.56 billion by 2025[1]. 24 hour ambulatory blood pressure monitoring (ABPM) 
is an important tool for risk stratification of individuals with arterial hypertension[2]. 
The pattern of nocturnal blood pressure (BP) relative to diurnal BP on ABPM can be 
categorized into i) dipper (≥10% reduction in average systolic blood pressure (SBP) at 
night) and ii) non-Dipper (<10% reduction in SBP at night) groups. Within the dipper 
group, there is a subset of subjects with exaggerated nocturnal BP dip (>20% 
reduction in SBP at night) termed extreme dippers. Likewise, there is a further 
subgroup within the non-dippers who demonstrate an increase in SBP overnight and 
these subjects are known as reverse dippers[3]. The nocturnal BP subtypes are 
associated with different levels of cardiovascular risk in hypertension, with non-
dipper status conferring the worse prognosis[4][5]. However, there remains debate 
about the impact of dipper status on target organ damage. For example, there is 
increasing evidence that extreme dipper status may result in increased 
cerebrovascular morbidity; extreme dippers had increased prevalence of ischaemic 
stroke in one study[6] and increased risk of intracerebral haemorrhage in another[7]. 
Studies assessing differences in cardiovascular structure and function have not 
yielded consistent results[8]. To date, the effect of dipper status subtypes on cardiac 
target damage has not been comprehensively investigated with cardiovascular 
magnetic resonance imaging (CMR), which is the current non-invasive gold-standard 
  
investigation to assess left ventricular (LV) volumes, mass and systolic function[9]. 
Consequently, we aimed to investigate the impact of nocturnal dipper status on 
cardiac structure and function using a comprehensive multi-parametric CMR 
protocol, assessing LV volumes and mass, burden of myocardial replacement fibrosis 
and myocardial deformational strain parameters. We hypothesized that non-dipper 
status would be associated with the most adverse cardiac remodeling/hypertrophy.  
 
Materials and methods 
Study population 
This was a prospective observational study. Inclusion criteria were consecutive 
patients being treated for hypertension referred for CMR with contemporaneous 
ABPM from the Bristol Heart Institute tertiary hypertension clinic between February 
2012 and April 2015. The local research ethics committee confirmed that the study 
conformed to the governance arrangements for research ethics committees. 
Subjects provided written consent. Baseline demographic and clinical characteristics 
were recorded, including prevalence of obstructive sleep apnea and number of 
nocturnal anti-hypertensive medications. Patients with any concomitant myocardial 
pathology that may confound the cardiac remodeling/hypertrophy were excluded. 
Exclusion criteria (Figure 1) consisted of: any evidence of moderate-severe valvular 
heart disease, acquired or inherited cardiomyopathy and suspected athlete’s heart, 
on the basis of clinical and International imaging consensus guidelines[10], and 
severely decreased estimated glomerular filtration rate (eGFR) <30ml/min/1.73m2. A 
history of myocardial ischaemia or infarction was not considered an exclusion 
criterion because both symptomatic and silent myocardial ischaemic are common in 
  
hypertensive patients with left ventricular hypertrophy, even in the absence of 
epicardial coronary artery disease and LVH itself is a recognized causes of myocardial 
ischaemia[11][12][13][14]. 
 
Ambulatory blood pressure monitoring 
Non-invasive 24-hour ABPM (Spacelabs, OSI Systems Company, USA) was performed 
during a weekday on the non-dominant arm with an automatic device[15]. The 
device obtained BP readings by the oscillometric method every 30 minutes for 24 
hours. The subjects were instructed to conduct their usual daily activities but remain 
still at the time of BP measurement. The International Database of Ambulatory 
Blood Pressure in relation to Cardiovascular Outcome (IDACO) criteria were used (10 
daytime measurements, 5 nighttime measurements) to determine satisfactory 
ABPM[16]. Nocturnal BP was defined as the mean BP readings from the time the 
patient went to bed until the time they got out of bed, with the remainder of the 
readings constituting the day time values. The ABPM data were analyzed with 
automated software to obtain mean overall/day-time/night-time systolic BP (SBP), 
diastolic BP (DBP) and mean arterial pressure (MAP). Dipper status was defined[3] as 
either:  
 
1) Dipper (≥10% and ≤20% reduction in average systolic blood pressure (SBP) at 
night),  
2) Extreme dipper (>20% reduction in SBP at night),  
3) Non-dipper (0-10% reduction in SBP at night) or  
4) Reverse dipper (<0% reduction in SBP at night, i.e. nocturnal increase in SBP). 
  
 
CMR cine protocol and analysis 
CMR was performed at 1.5T (Avanto, Siemens, Erlangen, Germany). Short-axis 
steady-state free precession (SSFP) cines with whole left ventricular (LV) coverage 
(8mm slice thickness, no slice gap, temporal resolution 38.1ms, echo time 1.07ms, 
in-plane pixel size 1.5 x 0.8mm) were used for the estimation LV mass (LVM) and 
volumes and indexed to body surface area as previously described[17]. In 
accordance with the Society of CMR guidelines[18], a validated[19] threshold-
detection software package (CMR42, Circle Cardiovascular Imaging Inc., Calgary, 
Canada) was used measure LVM, including papillary musculature and trabeculae in 
LVM estimation (Figure 1). LVH was defined as indexed LVM >95th percentile of 
established CMR reference ranges (men: 89-93g/m2 and women: 77-78g/m2 
depending on age)[17]. LV mass to volume ratio (M/V), akin to relative wall thickness 
on echocardiography, was calculated and an increased M/V defined as >95th gender-
specific percentile (men: >1.12g/ml and women: >1.14g/ml) from healthy 
volunteers, as described previously[20]. LV dilatation was defined as indexed EDV 
>95th percentile of the age and gender specific reference ranges. Left ventricular 
ejection fraction (LVEF) was reduced if <5th percentile of the same reference range. 
The CMR analysis was performed by an experienced CMR reader blinded to the 
ABPM data and CMR strain data.  
 
Defining patterns of left ventricular remodeling and hypertrophy 
Four patterns (Figure 2) of LV (left ventricular) remodeling / hypertrophy were 
defined as previously[21]: i) Normal = normal indexed LVM, normal indexed end-
  
diastolic volume (EDV) and normal mass to volume ratio (M/V), ii) LV remodeling = 
normal indexed LVM but increased M/V, iii) Concentric hypertrophy = increased 
indexed LVM, increased M/V, iv) Eccentric hypertrophy = increased LVM, increased 
indexed EDV, normal M/V and normal or reduced LVEF. 
 
CMR late gadolinium protocol and analysis 
Replacement myocardial fibrosis was assessed by late gadolinium enhancement 
(LGE) (Figure 1). An inversion-recovery fast gradient recall echo sequence performed 
10-15minutes following injection of 0.1mmol/kg intravenous gadobutrol (Gadovist, 
Bayer Pharma AG, Germany) as previously described[22]. The inversion time was 
personalized to achieve optimal myocardial nulling in each subject. LGE was visually 
assessed as a consensus between 2 expert CMR readers, blinded to the 
remodeling/hypertrophy, CMR strain and ABPM data.  
 
CMR strain imaging 
Strain imaging was performed off-line using 4-chamber, 2-chamber and short-axis 
stack SSFP cine images with voxel-tracking software (Tissue Tracking, CVM42, Circle 
Cardiovascular Imaging Inc., Calgary, Canada) as previously described[23] (Figure 1). 
The software defines the position of each myocardial voxel at end-diastole and 
tracks their location of the cardiac cycle in 2D. It is based on a previously described 
algorithm[24][25]. Briefly, endocardial and epicardial end-diastolic borders were 
defined excluding papillary muscles and trabeculae. The end-diastolic mitral valve 
annular plane was defined. Global longitudinal strain was the averaged strain from 4-
chamber and 2-chamber analysis. Circumferential strain was calculated as a mean 
  
value of mid myocardial segments from the short-axis cine 2D strain model, in order 
to minimize partial-volume averaging and through-plane motion at the base and 
apex. All strain analysis was performed by an experienced CMR reader blinded to the 
ABPM data and other CMR data. 
 
Statistical analysis 
Statistical analysis was performed using SPSS Version 21 (Armonk, NY, USA: IBM 
Corp). Normally distributed continuous variables were expressed as mean ± standard 
deviation and compared using one-way analysis of variance with Bonferroni post-hoc 
correction. Categorical variables were expressed as percentages and analysed using 
the Fisher’s exact test. Multiple linear regression was used to control for covariates 
of age, gender, body mass index, diabetes, day-time SBP, day-time DBP an day-time 
MAP with Bonferroni correction for multiple post-hoc comparisons. To determine 
the relative impact of day-time blood pressure levels and degree of nocturnal dip on 
indexed LV mass amongst dippers, linear regression analysis controlling for day-time 
systolic blood pressure was performed. Statistical significant was set at two-sided 
P<0.05. 
 
Results 
Study population 
One hundred and eleven hypertensive subjects were screened, 12 subjects were 
excluded due to concomitant cardiac pathology or inadequate CMR study (Figure 1), 
resulting in a final sample size of 99. The demographics and baseline clinical 
  
characteristics are displayed in Table 1. Dipper, extreme dipper, non-dipper and 
reverse dipper subgroups were matched in terms of age, gender and BMI. 
 
Blood pressure in dipper subgroups 
When all subjects with nocturnal dip <10% (non-dippers and reverse dippers, n = 51) 
were compared with all subjects with nocturnal dip ≥10% (dippers and extreme 
dippers, n = 48), the combined non-dipper and reverse dipper cohort had 
significantly higher mean overall ABPM SBP (157± 23 mmHg vs 147 ± 19 mmHg, P = 
0.008) and nocturnal ABPM SBP (155 ± 23 mmHg vs 130 ± 15 mmHg, P < 0.0001) 
compared to the combined dipper and extreme dipper cohort. However, when the 
individual dipper subgroups were compared, it was only the dipper subgroup (with 
nocturnal dip ≥10% and <20%) that exhibited significantly lower overall ABPM SBP 
compared to the non-dipper subgroup (with nocturnal dip 0-10%) (145 ± 18 mmHg 
vs 161 ± 23 mmHg, P = 0.009) (Table 1). The extreme dipper subgroup showed no 
significant difference in overall and day-time ABPM SBP compared with non-dipper 
and reverse dipper subgroups respectively.  
 
Cardiac structure and function in dipper subgroups  
When all subjects with nocturnal dip <10% (non-dippers and reverse dippers, n = 51) 
were compared with all subjects with nocturnal dip ≥10% (dippers and extreme 
dippers, n = 48), there was no significant difference in indexed LV mass (nocturnal 
dip ≥10%: 83±20 g/m2 vs nocturnal dip <10%: 89±25 g/m2, p = 0.208)(Figure 3). 
Contrary to the hypothesis, it was the extreme dippers whom demonstrated the 
highest prevalence of concentric LVH (67%) and had the highest indexed LV mass 
  
(103 ± 29 g/m2) (Table 2), despite the non-dippers and reverse dippers having similar 
overall and day-time ABPM SBP and significantly higher night-time ABPM DBP (Table 
1). Within the subgroup of patients with preserved nocturnal dip ≥10%, the extreme 
dipper cohort had significantly higher indexed LV mass than the dipper cohort (103 ± 
29 g/m2 vs dippers: 78 ± 15 g/m2, P = 0.021) (Table 2). However, there were no 
significant differences in systolic function in terms of LVEF, longitudinal strain and 
circumferential strain between the cohorts (Table 2 and Figure 3). The prevalence of 
myocardial replacement fibrosis was not significantly different between the 
subgroups (Table 2). 
 
Dipper versus extreme dipper 
To determine whether the increased indexed LV mass observed amongst the 
extreme dipper cohort compared to the dipper cohort was simply due to the 
association with higher day-time SBP, To determine whether the increased indexed 
LV mass observed amongst the extreme dipper cohort compared to the dipper 
cohort was simply due to the association with higher day-time SBP, a one-way 
analysis of covariance (ANCOVA) was performed to assess for persistent differences 
in indexed LV mass between extreme dipper and dippers, controlling for covariates 
of age, gender, BMI, diabetes, day-time SBP, day-time DBP and day-time MAP (Table 
3). Extreme dippers still demonstrated a significantly higher indexed LV mass 
compared to dippers (100 ± 6 g/m2 vs 79 ± 3 g/m2, P = 0.004) even after correcting 
for these covariates (Figure 3). 
 
  
Amongst dippers (n = 48), indexed LV mass correlated positively with percentage of 
nocturnal dip (R = 0.403, P = 0.005). Linear regression analysis was performed to 
assess the relationship between percentage nocturnal dip amongst dippers and 
indexed LV mass, controlling for day-time systolic blood pressure. A significant 
relationship persisted between indexed LV mass and percentage nocturnal dip (β = 
0.371, 95th confidence intervals: 0.479 – 3.477, p = 0.011) but not between indexed 
LV mass and day-time systolic blood pressure (β = 0.131, 95th confidence intervals: -
0.164 – 0.450, p = 0.352). Essentially, the exaggerated swing in SBP between day-
time and night-time is more likely to be the reason for more advances LV 
hypertrophic responses in extreme dippers compared to dippers, than higher day-
time SBP.  
 
Significant positive correlations with demonstrated between percentage nocturnal 
dip and: 1) peak circumferential strain (r = 0.412, p = 0.004) and 2) peak longitudinal 
strain (r = 0.345, p =0.016) but not with peak radial strain (r = -0.161, p = 0.276). 
Essentially, the greater the nocturnal dip, the worse the circumferential and 
longitudinal deformation, as these are negative indices by convention. Linear 
regression analysis was also performed to assess the relationship between LV strain 
indices and indexed LV mass, controlling for day-time systolic blood pressure. A 
significant relationship persisted between 1) peak circumferential strain (β = 0.393, 
95th confidence intervals: 0.099 – 0.599, p = 0.007) and 2) peak longitudinal strain (β 
= 0.321, 95th confidence intervals: 0.025 – 0.489, p = 0.031) with percentage 
nocturnal dip, but not with day-time systolic blood pressure in either of the 
statistical models respectively (β = 0.078, 95th confidence intervals: -0.037 – 0.065, p 
  
= 0.581), (β = 0.097, 95th confidence intervals: -0.32 – 0.063, p = 0.504). After 
correcting for day-time systolic blood pressure, there was no significant relationship 
between peak radial strain and percentage nocturnal dip (β = -0.215, 95th confidence 
intervals: -3.821 – 0.626, p = 0.155). Essentially, the exaggerated swing in SBP 
between day-time and night-time is more likely to be the reason for circumferential 
and longitudinal strain impairment in extreme dippers compared to dippers, rather 
than higher overall SBP. 
 
Discussion 
Summary of results  
We investigated the impact of dipper status on cardiac structure and function using 
CMR. We show that in the tertiary setting, extreme dippers exhibit the highest 
indexed LV mass, after correction for covariates of age, gender, BMI, diabetes, day-
time SBP/DBP/MAP, and that larger nocturnal drops in BP are associated with more 
advanced myocardial hypertrophy, independent of day-time SBP.  
 
Hypertensive LVH and dipper status  
The extreme dipper subgroup had the highest indexed LV mass and the highest 
prevalence of concentric LVH. There is heterogeneity in the literature regarding LV 
mass and dipper status. Importantly, it is only relatively recently that have dipping 
profiles have been subdivided into extreme dipper and reverse dipper subgroups. 
Ivanoic et al. did looked at all 4 dipper subgroups and demonstrated the highest 
prevalence of LVH in reverse dippers[26]. However, 69% of this cohort were 
untreated and LV mass was indexed to height2.7, which has been shown to 
  
systematically misclassify subjects regarding LVH presence [27]. The effect of drug 
treatment on the relationship of dipper status and cardiac function may be an 
important variable. For example, Muxfeldt et al. showed no significant differences in 
LV mass indexed to BSA amongst dipper, non-dipper, reverse dipper and extreme 
dipper subgroups in the context of resistant hypertension using 
echocardiography[28]. The current study differs from the previous studies by at least 
one of the following variables: 1) imaging modality for measuring LV mass (CMR), 2) 
definition of LVH (CMR specific cut-offs for age and gender indexed to BSA), 3) 
treatment status of patients (on treatment) and 4) type of patient (recruited from 
tertiary setting). Consequently, the current findings apply to a specific, but 
important, cohort of hypertensive patients. 
 
Mechanisms for LVH in extreme dippers 
Why extreme dippers develope the most LVH is not clear. Extreme dippers had 
comparable overall SBP levels compared to non-dippers and reverse dippers, 
suggesting a complex relationship beyond absolute BP level. 
 
An excessive early morning BP surge is associated with increased cardiovascular 
events[29]. The level of morning surge in BP has been demonstrated to be 
significantly associated with cardiovascular remodeling independent of 24 hour BP 
level, daytime BP variability and nocturnal BP decline in subjects >60 years old on 
antihypertensive medications[30]. Extreme dippers may be most prone to exhibit 
early morning surge in BP, which may account for the fact that extreme dipping has 
been associated with increased cardiovascular events[6][7]. A potential unifying 
  
explanation for these observations is that early morning surge may be a result of 
increased morning sympathetic activity[29]. Elevated day-time sympathetic nerve 
activity may result in not only day-time BP increases but also directly stimulate the 
myocardium potentially directly inducing LVH itself[31].  
 
Equally, the exaggerated fall in SBP at night may contribute to LVH in extreme 
dippers. Recently, we demonstrated that increased cerebrovascular resistance and 
reduced cerebral blood flow were present before the onset of increased muscle 
sympathetic nerve activity in the borderline hypertensive subjects, suggesting 
cerebral hypoperfusion may be a factor in triggering and exacerbating 
hypertension[32]. The exaggerated nocturnal drop in BP in extreme dippers could 
theoretically aggravate nocturnal cerebral perfusion and result in rebound increases 
in neurogenically-mediated sympathetic nerve activity. This relative nocturnal 
hypoperfusion may also help account for the increased cerebrovascular pathology 
identified in extreme dippers in some studies[6][7]. 
 
Extreme dipping may have direct cardiac effects. Theoretically, relative nocturnal 
hypotension may result in reduced myocardial perfusion pressure. If this were to fall 
below a critical threshold, it may trigger subclinical hypoperfusion/hypoxemia which 
itself will trigger low level myocardial inflammation and hypertrophy of the 
myocardium. Indeed, Kotsis et al.[33] previously demonstrated a significantly higher 
Gensini score (a computerized scoring system of coronary artery disease severity 
that depends on the degree of luminal narrowing, the geographic importance of 
each stenosis, the ejection fraction and possible collateral circulation of coronary 
  
arteries) in extreme dippers. Excessive sympathetic activity to the heart, for example 
via the aforementioned selfish brain hypothesis, may cause coronary 
vasoconstriction and potentially compound cardiac hypoperfusion during dipping.  
 
Clinical implications 
The post-hoc analysis of the current study suggests that it is the actual exaggerated 
nocturnal dip response that is associated with advanced LVH and not simply a higher 
daytime SBP. If the findings are validated in larger scale studies, this may have 
implications for anti-hypertensive regimens. It is common practice to suggest 
patients take their anti-hypertensive medications at night if they are developing pre-
syncopal symptoms during the day. Whilst several antihypertensive medications 
have appropriate pharmacodynamics and pharmacokinetics to allow single dosing, if 
the medications are taken at night, they may actually contribute to a larger 
nocturnal dip that could have pathological implications to the brain and heart as 
discussed above. More insight into this may be gained when the Hellenic Anglo 
Research into Morning Or Night antihypertensive drug deliverY (HARMONY) trial, a 
randomized cross-over trial of 100 participants comparing day-time and evening 
dosing of antihypertensive medications, reports its findings. Therefore, it is proposed 
that ABPM is performed, to define whether dipping occurs and to assess its extent, 
and the impact of long-acting and/or nocturnal anti-hypertensive regimens. 
 
 Limitations 
There are several limitations of this study. Firstly, the sample size is small. However, 
the increased precision, accuracy and reliability of CMR over 2-dimensional 
  
echocardiography increases the statistical power, reducing the sample size required 
to detect a statistically significant change in LV mass of 10g with 90% power (1 – β 
error) by 6-fold[34]. There is a relatively low prevalence of extreme and reverse 
dippers in our cohort but the proportions of these subgroups to the overall study 
size are comparable to previous echocardiographic studies[26][28]. However, one of 
the relative strengths of this study, in our opinion, is the real-world data captured by 
the study design, which was a prospectively maintained clinical database of 
consecutive hypertensive patients referred for CMR. The low prevalence of extreme 
dipper subgroups reflects our real world-practice. It represents a small but clinically 
important subgroup of patients with nocturnal dip >10%. We performed additional 
analyses looking at nocturnal blood pressure dip as a continuous variable, in addition 
to looking at pre-defined dipper subgroups. These findings provide further support 
to the notion that percentage of nocturnal dip is an important variable and mitigate 
against, although do not completely exclude, a type 1 error.  
 
This study was conducted in a specialist hypertension clinic. We, therefore, can only 
conclude that the findings are applicable in this tertiary setting. Further study is 
required to determine whether the same findings occur in, for example, untreated, 
newly diagnosed patients with hypertension in the primary care / community 
setting. 
 
Due to the prolonged subclinical course of the disease, it was not possible to 
accurately correct for the duration of subclinical and established hypertension. 
Finally, the dipper status of our subjects was only confirmed on a single ABPM 
  
reading, rather than two contemporaneous ABPM investigations. In addition, routine 
clinical CMR is likely to be inferior to echocardiography at assessing diastolic 
dysfunction and this has been previously investigated[35]. 
 
Conclusion 
 In the tertiary hypertension setting, extreme dippers with nocturnal dip >20% 
exhibit the most advanced hypertrophic response which appears to be independent 
of daytime BP and related to the relative swings in sympathetic activity and BP from 
night to day. This was contrary to the original hypothesis that non-dipper status 
would be associated with the most adverse cardiac remodeling/hypertrophy. If 
confirmed in larger studies, this may have implication on the recommendation of 
nocturnal dosing of anti-hypertensive medications. 
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Figure legends 
Figure 1. A flow chart showing the study exclusions. (HOCM = hypertrophic 
obstructive cardiomyopathy, LVNC = LV non-compaction cardiomyopathy, DCM = 
dilated cardiomyopathy, mod AR = moderate aortic regurgitation, AVR = aortic valve 
replacement, * = artefact from implantable loop recorder). Representative examples 
of the multi-parametric CMR protocol: A) Steady-state free precession left 
ventricular short-axis mid-cavity cines images at end-diastole with bloodpool 
threshold detection software analysis to define endocardial contours (red line) and 
manual definition of epicardial contours (green line) to estimate LV mass, LV 
volumes and LV ejection fraction (every other image shown for illustrative purposes), 
B) Voxel tracking software analysis, which is applied in a post-processing step to 
steady-state free precession images to derive estimates of longitudinal strain, 
circumferential strain and radial strain and C) Inversion-recovery late gadolinium 
enhancement left ventricular short-axis mid-cavity image at end-diastole 
demonstrating a cases of subtle replacement fibrosis at the right ventricular 
insertion points (solid white arrows). 
 
Figure 2. Different patterns of left ventricular remodeling and hypertrophy. 
 
Figure 3. Summary of key findings, including deformational strain (circumferential 
strain, longitudinal strain and radial strain) versus time graphs for the different 
dipper subgroups. *1one-way ANCOVA correction for covariates of age, gender, BMI, 
diabetes mellitus, day-time SBP, day-time DBP and day-time MAP. *2 Linear 
regression analysis. 
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